Clinical Trial Update: Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adjuvant GVAX vaccine therapy after surgery for pancreatic cancer has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• GVAX vaccine

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-09-02